We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » COMBO DRUGS: CHALLENGE, OPPORTUNITY FOR GENERICS
COMBO DRUGS: CHALLENGE, OPPORTUNITY FOR GENERICS
February 10, 2004
Pfizer’s new combination drug Caduet, which treats cholesterol and high blood pressure, presents both challenges and opportunities for generic firms, analysts say.